BALCHEM CORP

For the period ended Dec 31, 2023. Filed Feb 16, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 16, 2024

BCPC$173.54-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of December 31, 20 and

Consolidated Balance Sheets

December 31, 2023 and 2022

(Dollars in thousands, except share and per share data)

	2023	2022
Current assets:
Cash and cash equivalents	$64,447	$66,560
Accounts receivable, net of allowance for doubtful accounts of $908 and $1,226 atDecember 31, 2023 and 2022, respectively	125,284	131,578
Inventories, net	109,521	119,668
Prepaid expenses	7,798	4,903
Derivative assets	—	5,993
Other current assets	7,192	7,101
Total current assets	314,242	335,803
Property, plant and equipment, net	276,039	271,355
Goodwill	778,907	769,509
Intangible assets with finite lives, net	191,212	213,295
Right of use assets - operating leases	17,763	17,094
Right of use assets - finance lease	2,101	2,338
Other non-current assets	16,947	15,118
Total assets	$1,597,211	$1,624,512
Liabilities and Stockholders’ Equity
Current liabilities:
Trade accounts payable	$55,503	$57,322
Accrued expenses	40,855	36,745
Accrued compensation and other benefits	17,228	16,544
Dividends payable	25,717	23,129
Income tax payable	4,967	2,280
Operating lease liabilities - current	3,949	3,796
Finance lease liabilities - current	272	226
Total current liabilities	148,491	140,042
Revolving loan	309,569	440,569
Deferred income taxes	52,046	62,784
Operating lease liabilities - non-current	14,601	13,806
Finance lease liabilities - non-current	1,943	2,213
Other long-term obligations	16,577	26,814
Total liabilities	543,227	686,228
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding	—	—
Common stock, $.0667 par value. Authorized 120,000,000 shares; 32,254,728 shares issued and outstanding at December 31, 2023 and 32,152,787 shares issued and outstanding at December 31, 2022, respectively	2,152	2,145
Additional paid-in capital	145,653	128,806
Retained earnings	897,488	814,487
Accumulated other comprehensive income (loss)	8,691	(7,154)
Total stockholders’ equity	1,053,984	938,284
Total liabilities and stockholders’ equity	$1,597,211	$1,624,512

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.